December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

5.200 -0.420 (-7.48%)
Delayed Quote Updated: 2:43 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
24 25 Next >
News headline image
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill ↗
The natural psychedelics company responsible for creating the first standardized ayahuasca capsule, Filament Health Corp. 
Via Benzinga
News headline image
Jaguar Animal Health Exhibiting at Veterinary Cancer Society Collaborative Conference for Canalevia-CA1, the Company's FDA Conditionally Approved Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Jaguar Health Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Jaguar Health Reports 2022 Financial Results - Prescription Revenues up 179% to $11.9 Million
Via ACCESSWIRE
News headline image
Jaguar Health Announces Time Change for March 27th Investor Webcast to 8:00 AM EDT
Via ACCESSWIRE
News headline image
Jaguar Health's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Jaguar Health to Hold Investor Webcast Monday, March 27th at 8:30 AM EDT Regarding Q4 2022 Financials & Corporate Updates
Via ACCESSWIRE
News headline image
Jaguar Health Leveraging AI to Support Patient Access to Mytesi, the Company's FDA-Approved Prescription Drug
Via ACCESSWIRE
News headline image
Earnings Scheduled For March 24, 2023 ↗
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely to report earnings for its fourth quarter. • Caledonia Mining (AMEX:CMCL) is projected to report earnings for its fourth... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Leading Cancer Patient Advocate Kelly Shanahan, M.D., Joins Jaguar Health's Scientific Advisory Board
Via ACCESSWIRE
News headline image
Jaguar Health Celebrates U.N. International Day of Forests with Milestone of Providing Income to 20,000+ People Living in Tropical Rainforest Communities
Via ACCESSWIRE
News headline image
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets ↗
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.   
Via Benzinga
News headline image
Jaguar Health to Present at BioTrinity 2023 Conference’s R&D Spotlight on Rare Diseases
Via ACCESSWIRE
News headline image
Jaguar Health Receives Notice of Allowance for U.S. Patent for Lead FDA Approved Drug Crofelemer
Via ACCESSWIRE
News headline image
FDA Grants Orphan Drug Designation to Jaguar Health for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication in the US
Via ACCESSWIRE
News headline image
Jaguar Health Achieves Approximately 75% Enrollment in Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
Via ACCESSWIRE
News headline image
Jaguar Health Announces Initial Close in Private Placement Financing Round for Napo Therapeutics S.p.A.
Via ACCESSWIRE
News headline image
Jaguar Health Regains Compliance with Nasdaq’s Bid Price Requirement
Via ACCESSWIRE
News headline image
7 F-Rated Stocks to Sell in February ↗
Now that we’re getting an idea of what the market holds for us this year, we can make a fair estimate of F-rated stocks to sell this month. 
Via InvestorPlace
News headline image
Jaguar Health & SynWorld Technologies Mutually Agree to Terminate License and Commercialization Agreement for Canalevia for Treatment of Diarrhea in Dogs in China Given Jaguar’s 2023 Focus on Human Drug Development
Via ACCESSWIRE
News headline image
Here's Why Jaguar Health (JAGX) Stock Is Volatile Tuesday ↗
Jaguar Health Inc (NASDAQ: JAGX) shares are trading lower by some 7.73% to $5.01 going into the close of Tuesday's session. 
Via Benzinga
News headline image
Jaguar Health Engages Shareholder Intelligence Services, LLC (ShareIntel) to Monitor Trading Activity in Effort to Identify Possible Illegal Short Selling
Via ACCESSWIRE
News headline image
Jaguar Health Engages Former FDA Gastroenterology Division Deputy Director Andrew Mulberg, M.D. to Bolster Company's Regulatory Expertise
Via ACCESSWIRE
News headline image
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
News headline image
Jaguar Health Provides Updates Regarding Company's Focus on Rare and Orphan Disease Indications in the U.S. & Europe
Via ACCESSWIRE
News headline image
Jaguar Health Announces Completion of Key Milestone in Process of Establishing Indena S.p.A. as a Reliable Approved Crofelemer Manufacturer
Via ACCESSWIRE
News headline image
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 150 points on Monday. The Dow traded up 0.46% to 33,527.51 while the NASDAQ rose 1.55% to 11,313.03. The... 
Via Benzinga
News headline image
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 444.4% to $1.47 after the company announced it successfully completed the review of results from Milestone 7, a phase of its... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.